Gene · 7003
Papers2,415
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,415
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review). | Int J Oncol | 2022 | 35796022 | PubTator, text mining | PubMed |
| Comparison of chromatin accessibility landscapes during early development of prefrontal cortex between rhesus macaque and human. | Nat Commun | 2022 | 35794099 | PubTator, text mining | PubMed |
| A Tead1-Apelin axis directs paracrine communication from myogenic to endothelial cells in skeletal muscle. | iScience | 2022 | 35789856 | PubTator, text mining | PubMed |
| The Role of Lipid Metabolism in Gastric Cancer. | Front Oncol | 2022 | 35785165 | PubTator, text mining | PubMed |
| Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives. | J Adv Res | 2022 | 35777908 | PubTator, text mining | PubMed |
RNA-sequencing of myxoinflammatory fibroblastic sarcomas reveals a novel SND1::BRAF fusion and 3 different molecular aberrations with the potential to upregulate the TEAD1 gene including SEC23IP::VGLL3 and TEAD1::MRTFB gene fusions. | Virchows Arch | 2022 | 35776191 | PubTator, text mining | PubMed |
| Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications. | Front Genet | 2022 | 35774512 | PubTator, text mining | PubMed |
| YAP1 induces invadopodia formation by transcriptionally activating TIAM1 through enhancer in breast cancer. | Oncogene | 2022 | 35773411 | PubTator, text mining | PubMed |
| Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck. | Genes Chromosomes Cancer | 2022 | 35766997 | PubTator, text mining | PubMed |
| Mice with Trp53 and Rb1 deficiency in chondrocytes spontaneously develop chondrosarcoma via overactivation of YAP signaling. | Cell Death Dis | 2022 | 35760773 | PubTator, text mining | PubMed |
| Gastric cancer and genomics: review of literature. | J Gastroenterol | 2022 | 35751736 | PubTator, text mining | PubMed |
| Circular RNA as a Novel Biomarker and Therapeutic Target for HCC. | Cells | 2022 | 35741077 | PubTator, text mining | PubMed |
| Unraveling the Biology of Epithelioid Hemangioendothelioma, a TAZ-CAMTA1 Fusion Driven Sarcoma. | Cancers (Basel) | 2022 | 35740643 | PubTator, text mining | PubMed |
| TEADs serve as potential prognostic biomarkers and targets for human gastric cancer. | BMC Gastroenterol | 2022 | 35739490 | PubTator, text mining | PubMed |
| Diversity and Metabolic Activity of Fungi Causing Biodeterioration of Canvas Paintings. | J Fungi (Basel) | 2022 | 35736072 | PubTator, text mining | PubMed |
| RBFOX2-regulated TEAD1 alternative splicing plays a pivotal role in Hippo-YAP signaling. | Nucleic Acids Res | 2022 | 35699208 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Connective Tissue Growth Factor in Idiopathic Pulmonary Fibrosis: Breaking the Bridge. | Int J Mol Sci | 2022 | 35682743 | PubTator, text mining | PubMed |
| Aquapteridospora jiangxiensis, a new aquatic hyphomycetous fungus from a freshwater habitat in China. | Arch Microbiol | 2022 | 35678928 | PubTator, text mining | PubMed |
| Circular RNAs modulate Hippo-YAP signaling: functional mechanisms in cancer. | Theranostics | 2022 | 35673576 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7003/papers?page=40